In the pooled Phase 3 RECONNECT program (two identically designed double-blind, placebo-controlled trials enrolling 1,247 premenopausal women with HSDD), bremelanotide 1.75 mg administered subcutaneously on demand produced statistically significant improvements over placebo on both co-primary endpoints the Female Sexual Function Index Desire Domain and the Female Sexual Distress Scale (Desire/Arousal/Orgasm) Question 13 with P 99% (HPLC, LCMS) Container: Sealed metered nasal spray bottle Documentation: Batch-specific Certificate of Analysis (COA) available Storage, handling, intended-use, and regulatory information are provided in the corresponding tabs on this product page
PLoS ONE 11 , e0159524 (2016)
Rwnie skuteczna jest forma oralna
Injectable dose: 1-2mg daily subcutaneous Optional topical: 0.5-2% solution to problem areas Timing: Any time of day, food intake does not affect absorption Cycle length: 8-12 weeks on, 4-6 weeks off When to start: After 15-20lb weight loss or preemptively TB-500: Systemic Recovery and Inflammation Thymosin Beta-4 fragment, commonly known as TB-500, provides whole-body recovery support through mechanisms distinct from other healing peptides
We encourage you to take our free assessment quiz to determine your eligibility and receive a personalized treatment plan that prioritizes your safety and health
